International Headache Society

    • Cephalalgia
    • The Neuroscientist
    • Cephalagia Reports
  • About IHS
  • Resources/Events
  • Membership
  • News
  • Learning Centre
  • Member Login
Home > Effect of fremanezumab on quality of life and health status in migraine patients with documented inadequate response to 2-4 classes of migraine preventive medications in the randomized, placebo-controlled FOCUS study

Your privacy

We use cookies to improve your experience on our site and to show you personalised advertising.

To find out more, read our privacy policy and cookie policy.

Back to top
  • IHS Links
  • IHS Sponsors
  • IHS Privacy Policy
  • Contact the IHS
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • YouTube
International Headache Society, 6th Floor, 2 London Wall Place, London, EC2Y 5AU, United Kingdom. The International Headache Society is a UK registered charity.
Registered Charity Number: 1042574 ©2020 International Headache Society